Our work makes others take notice

When you make an impact on the future of proximity based biologics, you make a few headlines in the process. Read what others are saying about InduPro and see what we’ve published.

News & Publications

In The News 09/04/2024

Therapeutic potential of cis-targeting bispecific antibodies

In this review, InduPro Scientific Founders and Leadersip- Rob Oslund, Pamela Holland, Scott Lesley and Niyi Fadeyi- discuss the progress and impact of cis-bispecific antibodies (cis-bsAbs) in the clinic, their wide-ranging clinical applications, and untangle the intricacies of improving bsAb discovery and development.

In The News 06/14/2024

Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease

On Thursday, a startup named InduPro, founded by three scientists from Merck — including two who invented the protein mapping technique — revealed its plans to refine the technology and design antibody drugs. InduPro, whose name is a portmanteau of “induced proximity,” has raised $85 million in Series A financing, the company told Endpoints News […]

In The News 06/13/2024

InduPro Announces $85 Million Series A Financing, Appoints Prakash Raman, Ph.D. as CEO to Advance Next-Generation, Proximity-Based Protein Therapeutics for the Treatment of Cancer and Autoimmune Diseases

SEATTLE and CAMBRIDGE, Mass., June 13, 2024 /PRNewswire/ — InduPro, Inc., a biotechnology company defining protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, today announced an $85 million Series A financing co-led by The Column Group and Vida Ventures with participation from investors, including MRL Ventures Fund (the therapeutics-focused venture fund of Merck & Co, Inc.), […]

Contact Us

InduPro Seattle
1930 Boren Ave Suite 200
Seattle, WA 98101

InduPro Boston
215 First Street, Suite 150
Cambridge, MA 02142

Phone
(206) 593-5005

General Inquiries:
[email protected]

undupro location